# A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

> **NCT06323265** · — · UNKNOWN · sponsor: **Hebei Medical University Fourth Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Extensive Stage Small Cell Lung Cancer

## Interventions

- **DRUG:** Adebrelimab + chemotherapy
- **RADIATION:** ±chest radiotherapy

## Key facts

- **NCT ID:** NCT06323265
- **Lead sponsor:** Hebei Medical University Fourth Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-26
- **Primary completion:** 2025-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06323265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06323265, "A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06323265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*